These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 34502201)

  • 1. Dissecting Breast Cancer Circulating Tumor Cells Competence via Modelling Metastasis in Zebrafish.
    Martínez-Pena I; Hurtado P; Carmona-Ule N; Abuín C; Dávila-Ibáñez AB; Sánchez L; Abal M; Chaachou A; Hernández-Losa J; Cajal SRY; López-López R; Piñeiro R
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling metastasis in zebrafish unveils regulatory interactions of cancer-associated fibroblasts with circulating tumour cells.
    Hurtado P; Martínez-Pena I; Yepes-Rodríguez S; Bascoy-Otero M; Abuín C; Fernández-Santiago C; Sánchez L; López-López R; Piñeiro R
    Front Cell Dev Biol; 2023; 11():1076432. PubMed ID: 36949770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
    Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
    Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
    J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
    Aceto N; Bardia A; Miyamoto DT; Donaldson MC; Wittner BS; Spencer JA; Yu M; Pely A; Engstrom A; Zhu H; Brannigan BW; Kapur R; Stott SL; Shioda T; Ramaswamy S; Ting DT; Lin CP; Toner M; Haber DA; Maheswaran S
    Cell; 2014 Aug; 158(5):1110-1122. PubMed ID: 25171411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Zebrafish Embryo to Dissect the Early Steps of the Metastasis Cascade.
    Follain G; Osmani N; Fuchs C; Allio G; Harlepp S; Goetz JG
    Methods Mol Biol; 2018; 1749():195-211. PubMed ID: 29525999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proportion of circulating tumor cell clusters increases during cancer metastasis.
    Suo Y; Xie C; Zhu X; Fan Z; Yang Z; He H; Wei X
    Cytometry A; 2017 Mar; 91(3):250-253. PubMed ID: 28009470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
    Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
    Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin.
    Fu A; Ma S; Wei N; Tan BX; Tan EY; Luo KQ
    Oncotarget; 2016 Aug; 7(31):50239-50257. PubMed ID: 27384484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
    Wang C; Mu Z; Chervoneva I; Austin L; Ye Z; Rossi G; Palazzo JP; Sun C; Abu-Khalaf M; Myers RE; Zhu Z; Ba Y; Li B; Hou L; Cristofanilli M; Yang H
    Breast Cancer Res Treat; 2017 Jan; 161(1):83-94. PubMed ID: 27771841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Color-coded Imaging of the Circulating Tumor Cell Microenvironment.
    Satake T; Suetsugu A; Nakamura M; Kunisada T; Shimizu M; Saji S; Moriwaki H; Hoffman RM
    Anticancer Res; 2018 Oct; 38(10):5635-5638. PubMed ID: 30275181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.